References

  1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD and Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci. USA 1980; 77 (12): 7415-7419. PubMed | Google Scholar

  2. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D and Gallo RCA. New subtype of human T-cell leukaemia virus (HTLV-2) associated with a T-cell variant of hairy cell leukaemia. Science. 1982; 218( 4572) 571-573. PubMed | Google Scholar

  3. Fischer HE. Human T-Lymphotropic Virus Types I and II: Screening and Seroprevalence in Blood Donors. Current issues in Transfusion Medicine. 1995; 3 (4). PubMed | Google Scholar

  4. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calendar A and de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985; 2(8452); 407-410. PubMed | Google Scholar

  5. Manns, A, and W A Blattner. The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease. Transfusion. 1991; 31:67-7. PubMed | Google Scholar

  6. Adedayo, OA and Shehu, SM. Human T-cell lymphotropic virus type 1 (HTLV-1) and lymphoid malignancies in Dominica: A seroprevalence study. Am J Hematol. 2004; 77 (4):336-339. PubMed | Google Scholar

  7. Williams CKO, Alabi GO, Junaid TA, Saxinger C, Gallo RC, Blayney DW, Blattner WA & Greaves MF. Human T-cell leukaemia virus associated lymphoproliferative disease: report of 2 cases in Nigeria. Br Med J. 1984; 288 (6429): 1495-1496. PubMed | Google Scholar

  8. Clark JW, Robert-Guroff M, Ikehara O, Henzan E and Blattner WA. Human T-cell leukaemia-lymphoma virus type I and adult T-cell leukaemia-lymphoma in Okinawa. Cancer Research. 1985; 45 (6): 2849-2852. PubMed | Google Scholar

  9. Wolfe ND, Heneine W, Carr JK et al. Emergence of unique primate T-lymphotropic viruses among Central African bushmeat hunters. Proc Natl Acad Sci. USA 2005; 102 (22): 7994-799. PubMed | Google Scholar

  10. Sarkodie F, Adarkwa M, Adu-Sarkodie Y, Candotti D, Acheampong J W and Allain J P. Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sanguini.s 2001; 80 (3): 142-147. PubMed | Google Scholar

  11. Blattner WA, Kalyanaraman VS, Robert-Guroff M et al. The human type C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T-cell leukaemia/lymphoma. Int J Cance.r 1982; 30 (3): 257-264. PubMed | Google Scholar

  12. Hunsmann G, Bayer H, Schneider J, Schmitz H, Kern P, Dietrich M, Buttner DW, Goudeau AM, Kulkarni G and FLeming AF. Antibodies to ATLV/HTLV-1n Africa. Med Microbiol Immunol. 1984; 173(3): 167-170. PubMed | Google Scholar

  13. FLeming AF, Yamamoto N, Bhusnurmath SR, Maharajan R, Schneider J and Hunsmann G. Antibodies to ATLV (HTLV) in Nigerian blood donors and patients with chronic lymphatic leukaemia or lymphoma. Lancet.1983; ii: 334-335. PubMed | Google Scholar

  14. Hino S, Yamaguchi K, Katamine S, et al. Mother-to-child transmission of human T-cell leukaemia virus type-I. Jpn J Cancer Res (Gann). 1985; 76: 474-80. PubMed | Google Scholar

  15. Ureta-Vidal A, Angelin-Duclos C, Tortevoye P, Murphy E, Lepère JF, Buigues RP, Jolly N, Joubert M, Carles G, Pouliquen JF, de Thé G, Moreau JP and Gessain A. Mother-to-child transmission of human T-cell-leukaemia/lymphoma virus type I: Implication of high antiviral antibody titer and high proviral load in carrier mothers. International Journal of Cancer. 1999; 82(6): 832-836. PubMed | Google Scholar

  16. Roucoux DF, Wang B, Smith D, et al. A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-2. J Infect Dis. 2005; 191(9): 1490-1497. PubMed | Google Scholar

  17. Okochi K, Sato H and Hinuma Y. A retrospective study on transmission of adult T cell leukaemia virus by blood transfusion: seroconversion in recipients. Vox Sanguinis. 1984; 46(5): 245-253. PubMed | Google Scholar

  18. Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M and Hanchard B. A prospective study of transmission by transfusion of HTLV-1 and risk factors associated with seroconversion. Int J Cancer. 1992; 51(6): 886-891. PubMed | Google Scholar

  19. Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B and Kaplan JE. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med. 1992; 326: 375-380. PubMed | Google Scholar

  20. Kusuhara K, Sonoda S, Takahashi K, Tokugawa K, Fukushige J and Ueda K. Mother-to-child transmission of human T-cell leukaemia virus type-I (HTLV-1): a fifteen-year follow-up study in Okinawa, Japan. Int J Cancer. 1997; 40:755-7. PubMed | Google Scholar

  21. Takahashi K, Takezaki T, Oki T, Kawakami K, Yashiki S, Fujiyoshi T, Usuku K, Mueller N, Osame M, Miyata K, et al. Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. Int J Cancer. 1991; 49(5): 673-677. PubMed | Google Scholar

  22. Nyambi P, Ville Y, Louwagie J, Bedjabaga I, Glowaczower E, Peeters M, Kerouedan D, Dazza M, Larouze B, van der Groen G, and Delaporte E. Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-1/2) in Gabon: a prospective follow-up of 4 years. J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 12(2): 187-192. PubMed | Google Scholar

  23. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J, Nomura H and Okochi K. Intrafamilial transmission of adult T cell leukaemia virus. J infect Dis. 1986; 154(5): 851-857. PubMed | Google Scholar

  24. Murphy EL, Figueroa JP, Gibbs WN, Brathwaite A, Holdingcobham M, Waters D, Cranston B, Hanchard B and Blattner WA. Sexual transmission of human T-lymphotropic virus type I (HTLV-1). Ann intern Med. 1989; 111(7): 555-560. PubMed | Google Scholar

  25. Donegan E, Transfusion Safety Study (TSS) Group. Comparison of HTLV-1/2 with HIV-1 transmission by component type and shelf storage before administration. Transfusion. 1989; 29(7): 567-657. PubMed | Google Scholar

  26. Feigal E, Murphy E, Vranizan K, Bacchetti P, Chaisson R, Drummond JE, Blattner W, McGrath M, Greenspan J and Moss A. Human T-cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. J Infect Dis .1991; 164(1): 36-42. PubMed | Google Scholar

  27. Stigum H, Magnus P, Samdal HH and Nord E. Human T -cell lymphotrophic virus testing of blood donors in Norway: a cost-effect model. Int J Epidemiol. 2000; 29(6): 1076-1084. PubMed | Google Scholar

  28. Centre for Disease Control and Prevention (CDC). Licensure of screening test for antibody to HTLV-1. Morbidity and Mortality Weekly Report .1988; 37(48): 736-747. PubMed | Google Scholar

  29. Anonymous. HTLV-1 - A screen too many?. Lancet. 1990; 336(8724): 1161. PubMed | Google Scholar

  30. http//www.statisticshowto.com. Accessed on 10th January 2012.

  31. Analo HI, Akanmu AS, Akinsete I, Njoku OS and Okany CC. Seroprevalence of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies. Central African Journal of Medicine .1998; 44(5): 130-134. PubMed | Google Scholar

  32. FLeming AF, Maharajan R, Abraham M, Kulkarni AG, Bhusnurmath SR, Okpara RA, Williams E, Akinsete I, Schneider J, Bayer H and Hunsmann G. Antibodies to HTLV-1 in Nigerian blood-donors, their relatives and patients with leukaemias, lymphomas and other diseases. Int J Cancer. 1986; 38(6): 809-813. PubMed | Google Scholar

  33. Williams AE, Fang CT, Slamon DJ, Poiesz BJ, Sandler SG, Darr WF Jr, Shulman G, McGowan EI, Douglas DK, Bowman RJ, Peeetoom F, Kleinman SH, Lenes B and Dodd RY. Seroprevalence and epidemiological correlates of HTLV-1 infection in US blood donors. Science. 1988; 240(4852): 643-646. PubMed | Google Scholar

  34. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF & Sher G. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. Can Med Assoc J. 2003; 169(8): 767-773. PubMed | Google Scholar

  35. Courouce AM, Pillonel J, Lemaire JM, Maniez M and Brunet JB. Seroepidemiology of HTLV-1/2 in universal screening of blood donations in France. Aids. 1993; 7(6): 841-847. PubMed | Google Scholar

  36. Tseliou PM, Spanakis N, Spiliotakara A, Politis C, Legakis NJ and Tsakris A. HTLV-1 and -II in southwestern Greece. Transfusion. 2003; 43(11): 1641-1642. PubMed | Google Scholar

  37. Murphy EL, Wilks R, Hanchard B, Cranston B, Figueroa JP, Gibbs WN, Murphy J and Blattner WA. A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-1) in Jamaica. Int J Epidemiol. 1996; 25: 1083-1089. PubMed | Google Scholar

  38. Olaleye OD, Bernstein L, Sheng Z. Type specific immune response to HTLV-1/2 infections in Nigeria. American Journal of Tropical Medicine and Hygiene. 1994; 50(4): 479-86. PubMed | Google Scholar

  39. Olaleye DO, Omotade OO, Sheng Z, Adeyemo AA and Odaibo GN. HTLV types I and II infections in Mother-Child pairs in Nigeria. Journal of Tropical Pediatrics. 1999; 45(2): 66-70. PubMed | Google Scholar